CE vs OGEN · rev $10.28B vs rev $37.7K
Celanese Corporation (CE) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CE currently screens at market cap $5.92B. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CE and OGEN stock pages for the full models.
Not investment advice.